NCT01224002 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Donaldson M, Goodchild JH
Oral health of the methamphetamine abuser. Am J Health Syst Pharm. 2006 Nov 1;63(21):2078-82. Erratum in: Am J Health Syst Pharm. 2006 Nov 15;63(22):2180.
Klasser GD, Epstein J
Methamphetamine and its impact on dental care. J Can Dent Assoc. 2005 Nov;71(10):759-62.
Shaner JW
Caries associated with methamphetamine abuse. J Mich Dent Assoc. 2002 Sep;84(9):42-7.

A Comparative Feasibility Study to Assess the Prevalence and Severity of Dental Caries in Incarcerated People Who Abuse Methamphetamine

Clinical trial NCT01224002 - References